[{"orgOrder":0,"company":"Robert Wood Johnson Barnabas Health","sponsor":"Brielle Orthopedics | University Orthopedics Associates","pharmaFlowCategory":"DU","therapeuticArea":"Orthopedics\/Orthopedic Surgery","country":"","productType":"Other Small Molecule","year":"2021","type":"Inapplicable","leadProduct":"Methylprednisolone","moa":"||Glucocorticoid receptor","graph1":"Orthopedics\/Orthopedic Surgery","graph2":"Phase II\/ Phase III","graph3":"Robert Wood Johnson Barnabas Health","amount2":0,"highestDevelopmentShortName":"Ph II\/III","therapeuticAreaShortName":"Orthopedics","amount2New":0,"dosageForm":"Tablet","sponsorNew":"Robert Wood Johnson Barnabas Health \/ Brielle Orthopedics | University Orthopedics Associates","highestDevelopmentStatusID":"9","companyTruncated":"Robert Wood Johnson Barnabas Health \/ Brielle Orthopedics | University Orthopedics Associates"}]

Find Clinical Drug Development Pipelines & Deals | PipelineProspector

Xls
Filters Filter
×
FILTER:
filter
Company Name
    filter

    Year

      filter

      DEALS // DEV.

        filter

        Country

          filter
          Sponsor
            filter

            Therapeutic Area

              filter

              Study Phase

                filter

                Deal Type

                  filter

                  Product Type

                    filter

                    Dosage Form

                      filter

                      Lead Product

                        filter

                        Target

                          Loading...

                          Therapeutic Area by Lead Product

                          Study Phase by Lead Product

                          Company by Lead Product

                          Top Deals by Deal Size (USD bn)

                          01

                          Robert Wood Johnson Barnabas Health

                          Country arrow
                          EPSC
                          Not Confirmed

                          Robert Wood Johnson Barnabas Health

                          Country arrow
                          EPSC
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Other Small Molecule

                          Upfront Cash : Inapplicable

                          August 12, 2021

                          Lead Product(s) : Methylprednisolone,Inapplicable

                          Therapeutic Area : Orthopedics/Orthopedic Surgery

                          Highest Development Status : Phase II/ Phase III

                          Sponsor : Brielle Orthopedics | University Orthopedics Associates

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          02

                          University of South Florida

                          Country arrow
                          EPSC
                          Not Confirmed

                          University of South Florida

                          Country arrow
                          EPSC
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Exparel

                          Product Type : Other Small Molecule

                          Upfront Cash : Inapplicable

                          November 13, 2018

                          Lead Product(s) : Bupivacaine,Inapplicable

                          Therapeutic Area : Orthopedics/Orthopedic Surgery

                          Highest Development Status : Phase II/ Phase III

                          Sponsor : Pacira BioSciences

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          03

                          Unity Health Toronto

                          Country arrow
                          EPSC
                          Not Confirmed

                          Unity Health Toronto

                          Country arrow
                          EPSC
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Controlled Substance

                          Upfront Cash : Inapplicable

                          September 18, 2018

                          Lead Product(s) : Cannabinol,Inapplicable

                          Therapeutic Area : Orthopedics/Orthopedic Surgery

                          Highest Development Status : Phase II/ Phase III

                          Sponsor : Inapplicable

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank